AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
CELLULAR BUT NOT PLASMA PHARMACOKINETICS OF LOMETREXOL CORRELATE WITHTHE OCCURRENCE OF CUMULATIVE HEMATOLOGICAL TOXICITY
Authors: SYNOLD TW NEWMAN EM CARROLL M MUGGIA FM GROSHEN S JOHNSON K DOROSHOW JH
Citation: Tw. Synold et al., CELLULAR BUT NOT PLASMA PHARMACOKINETICS OF LOMETREXOL CORRELATE WITHTHE OCCURRENCE OF CUMULATIVE HEMATOLOGICAL TOXICITY, Clinical cancer research, 4(10), 1998, pp. 2349-2355
COMPARISON OF AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION IN HUMAN CD34(-BLOOD PROGENITOR CELLS FROM ADULT DONORS WITH HIV-1 INFECTION OR CANCER() PERIPHERAL)
Authors: YAM PY YEE JK ITO JI SNIECINSKI I DOROSHOW JH FORMAN SJ ZAIA JA
Citation: Py. Yam et al., COMPARISON OF AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION IN HUMAN CD34(-BLOOD PROGENITOR CELLS FROM ADULT DONORS WITH HIV-1 INFECTION OR CANCER() PERIPHERAL), Experimental hematology, 26(10), 1998, pp. 962-968
ANTINEOPLASTIC ACTIVITY OF CONTINUOUS EXPOSURE TO DEXRAZOXANE - POTENTIAL NEW ROLE AS A NOVEL TOPOISOMERASE-II INHIBITOR
Authors: SYNOLD TW TETEF ML DOROSHOW JH
Citation: Tw. Synold et al., ANTINEOPLASTIC ACTIVITY OF CONTINUOUS EXPOSURE TO DEXRAZOXANE - POTENTIAL NEW ROLE AS A NOVEL TOPOISOMERASE-II INHIBITOR, Seminars in oncology, 25(4), 1998, pp. 93-99
PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS
Authors: MORGAN RJ NEWMAN EM DOROSHOW JH MCGONIGLE K MARGOLIN K RASCHKO J CHOW W SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V CARROLL M VASILEV S AKMAN S COLUZZI P WAGMAN L LONGMATE J PAZ B YEN Y KLEVECZ R
Citation: Rj. Morgan et al., PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS, Cancer research, 58(13), 1998, pp. 2793-2800
HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT
Authors: MORGAN RJ DOROSHOW JH VENKATARAMAN K CHANG K RASCHKO J SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V MARGOLIN K FORMAN S AKMAN S COLUZZI P AHN C WEISS L GADGIL U HARRISON J
Citation: Rj. Morgan et al., HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT, Clinical cancer research, 3(12), 1997, pp. 2337-2345
CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
Authors: SOSMAN JA ARONSON FR SZNOL M ATKINS MB DUTCHER JP WEISS GR ISAACS RE MARGOLIN KA FISHER RI ERNEST ML MIER J OLEKSOWICZ L ECKHARDT JR LEVITT D DOROSHOW JH
Citation: Ja. Sosman et al., CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY, Clinical cancer research, 3(1), 1997, pp. 39-46
PHASE-II STUDY OF INTRATUMORAL INJECTION OF HLA-B7 BETA-2M PLASMID DNA-CATIONIC LIPID COMPLEX (ALLOVECTIN-7) THERAPY FOR METASTATIC MALIGNANT-MELANOMA (MMM)/
Authors: HERSH EM STOPECK AT SILVER HKB CHANG AE DOROSHOW JH RUBIN J RHINEHART J STAHL SM SCHREIBER AB
Citation: Em. Hersh et al., PHASE-II STUDY OF INTRATUMORAL INJECTION OF HLA-B7 BETA-2M PLASMID DNA-CATIONIC LIPID COMPLEX (ALLOVECTIN-7) THERAPY FOR METASTATIC MALIGNANT-MELANOMA (MMM)/, Cancer gene therapy, 4(6), 1997, pp. 124-124
HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL
Authors: SOMLO G DOROSHOW JH FORMAN SJ ODOMMARYON T LEE J CHOW W HAMASAKI V LEONG L MORGAN R MARGOLIN K RASCHKO J SHIBATA S TETEF M YEN Y SIMPSON J MOLINA A
Citation: G. Somlo et al., HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL, Journal of clinical oncology, 15(8), 1997, pp. 2882-2893
PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: NEWMAN EM CARROLL M AKMAN SA CHOW W COLUZZI P HAMASAKI V LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW SHIBATA S SOMLO G TETEF M YEN Y AHN CW DOROSHOW JH
Citation: Em. Newman et al., PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 254-258
AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION OF CD34-CELLS (HSC) - COMPARISON IN HSC FROM HIV-1-INFECTED AND NONINFECTED SOURCES( HEMATOPOIETIC STEM)
Authors: YAM PY YEE JK ITO JI SNIECINSKI I DOROSHOW JH FORMAN SJ ZAIA JA
Citation: Py. Yam et al., AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION OF CD34-CELLS (HSC) - COMPARISON IN HSC FROM HIV-1-INFECTED AND NONINFECTED SOURCES( HEMATOPOIETIC STEM), Blood, 90(10), 1997, pp. 4639-4639
RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN COMBINATION WITH G-CSF ISSAFE AND EFFECTIVE AS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZER
Authors: SOMLO G SNIECINSKI I BRENT J TERVEER A CHOW W FORMAN S HAMASAKI V LEONG L MORGAN R MARGOLIN K RADER D RASCHKO J SHIBATA S TETEF M YEN Y MOLINA A ASHBY M JONES D DOROSHOW JH
Citation: G. Somlo et al., RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN COMBINATION WITH G-CSF ISSAFE AND EFFECTIVE AS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZER, Blood, 90(10), 1997, pp. 2513-2513
EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM)
Authors: SOMLO G SNIECINSKI I ODOMMARYON T NOWICKI B CHOW W HAMASAKI V LEONG L MARGOLIN K MORGAN R RASCHKO J SHIBATA S TETEF M MOLINA A BERENSON RJ FORMAN SJ DOROSHOW JH
Citation: G. Somlo et al., EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM), Blood, 89(5), 1997, pp. 1521-1528
BIOCHEMICAL MODULATION OF FLUOROPYRIMIDINES - IS THERE AN OPTIMAL (6R,S)LEUCOVORIN DOSE AND SCHEDULE
Authors: DOROSHOW JH
Citation: Jh. Doroshow, BIOCHEMICAL MODULATION OF FLUOROPYRIMIDINES - IS THERE AN OPTIMAL (6R,S)LEUCOVORIN DOSE AND SCHEDULE, Journal of the National Cancer Institute, 88(7), 1996, pp. 393-395
FAILURE OF PRETREATMENT WITH INTRAVENOUS FOLIC-ACID TO ALTER THE CUMULATIVE HEMATOLOGIC TOXICITY OF LOMETREXOL
Authors: MUGGIA FM SYNOLD TW NEWMAN EM JEFFERS S LEICHMAN LP DOROSHOW JH JOHNSON K GROSHEN S
Citation: Fm. Muggia et al., FAILURE OF PRETREATMENT WITH INTRAVENOUS FOLIC-ACID TO ALTER THE CUMULATIVE HEMATOLOGIC TOXICITY OF LOMETREXOL, Journal of the National Cancer Institute, 88(20), 1996, pp. 1495-1496
SIMPLE AND SENSITIVE METHOD FOR THE QUANTITATIVE-ANALYSIS OF LOMETREXOL IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
Authors: SYNOLD TW XI BX NEWMAN EM MUGGIA FM DOROSHOW JH
Citation: Tw. Synold et al., SIMPLE AND SENSITIVE METHOD FOR THE QUANTITATIVE-ANALYSIS OF LOMETREXOL IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 683(2), 1996, pp. 245-249
TREATMENT OF GERM-CELL CANCER WITH 2 CYCLES OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT
Authors: MARGOLIN K DOROSHOW JH AHN C HAMASAKI V LEONG L MORGAN R RASCHKO J SHIBATA S SOMLO G TETEF M
Citation: K. Margolin et al., TREATMENT OF GERM-CELL CANCER WITH 2 CYCLES OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT, Journal of clinical oncology, 14(10), 1996, pp. 2631-2637
BICISTRONIC AND 2-GENE RETROVIRAL VECTORS FOR USING MDR1 AS A SELECTABLE MARKER AND A THERAPEUTIC GENE
Authors: METZ MZ MATSUMOTO L WINTERS KA DOROSHOW JH KANE SE
Citation: Mz. Metz et al., BICISTRONIC AND 2-GENE RETROVIRAL VECTORS FOR USING MDR1 AS A SELECTABLE MARKER AND A THERAPEUTIC GENE, Virology, 217(1), 1996, pp. 230-241
RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: MEYSKENS FL KOPECKY KJ TAYLOR CW NOYES RD TUTHILL RJ HERSH EM FEUN LG DOROSHOW JH FLAHERTY LE SONDAK VK
Citation: Fl. Meyskens et al., RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of the National Cancer Institute, 87(22), 1995, pp. 1710-1713
A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA
Authors: WEISS GR MARGOLIN KA SZNOL M ATKINS MB OLEKSOWICZ L ISAACS R SOSMAN JA DOROSHOW JH TREHU EG DUTCHER JP FISHER RI
Citation: Gr. Weiss et al., A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 52-56
CARBOPLATIN INFUSION IN RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP TRIAL
Authors: WELBORN JL KOPECKY KJ MEYERS FJ VEITH R SHURAFA M DOROSHOW JH BALCERZAK SP APPELBAUM FR
Citation: Jl. Welborn et al., CARBOPLATIN INFUSION IN RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP TRIAL, Leukemia, 9(7), 1995, pp. 1126-1129
PHASE-I TRIAL OF CARBOPLATIN AND INFUSIONAL CYCLOSPORINE IN ADVANCED MALIGNANCY
Authors: MORGAN RJ MARGOLIN K RASCHKO J AKMAN S LEONG L SOMLO G SCANLON K AHN C CARROLL M DOROSHOW JH
Citation: Rj. Morgan et al., PHASE-I TRIAL OF CARBOPLATIN AND INFUSIONAL CYCLOSPORINE IN ADVANCED MALIGNANCY, Journal of clinical oncology, 13(9), 1995, pp. 2238-2246
PHASE-II STUDY OF FLUOROURACIL AND ITS MODULATION IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: LEICHMAN CG FLEMING TR MUGGIA FM TANGEN CM ARDALAN B DOROSHOW JH MEYERS FJ HOLCOMBE RF WEISS GR MANGALIK A MACDONALD JS
Citation: Cg. Leichman et al., PHASE-II STUDY OF FLUOROURACIL AND ITS MODULATION IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(6), 1995, pp. 1303-1311
EFFECT OF LOW-DOSE PROPHYLACTIC DOPAMINE ON HIGH-DOSE CISPLATIN-INDUCED ELECTROLYTE WASTING, OTOTOXICITY, AND EPIDERMAL GROWTH-FACTOR EXCRETION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
Authors: SOMLO G DOROSHOW JH LEVRAN A AHN DC HWANG L RASCHKO JW FORMAN SJ MARGOLIN KA MORGAN RJ LEONG LA HAMASAKI VK CHOW WA MOLINA A AHMAD B AKMAN SA KOJIAN A MENARD P
Citation: G. Somlo et al., EFFECT OF LOW-DOSE PROPHYLACTIC DOPAMINE ON HIGH-DOSE CISPLATIN-INDUCED ELECTROLYTE WASTING, OTOTOXICITY, AND EPIDERMAL GROWTH-FACTOR EXCRETION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL, Journal of clinical oncology, 13(5), 1995, pp. 1231-1237
SURVEY OF THE PROVISION OF SUPPORTIVE CARE SERVICES AT NATIONAL-CANCER-INSTITUTE - DESIGNATED CANCER CENTERS
Authors: COLUZZI PH GRANT M DOROSHOW JH RHINER M FERRELL B RIVERA L
Citation: Ph. Coluzzi et al., SURVEY OF THE PROVISION OF SUPPORTIVE CARE SERVICES AT NATIONAL-CANCER-INSTITUTE - DESIGNATED CANCER CENTERS, Journal of clinical oncology, 13(3), 1995, pp. 756-764
GLUTATHIONE-PEROXIDASE AND OXIDATIVE STRESS
Authors: DOROSHOW JH
Citation: Jh. Doroshow, GLUTATHIONE-PEROXIDASE AND OXIDATIVE STRESS, Toxicology letters, 82-3, 1995, pp. 395-398
Risultati: 1-25 | 26-48